Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation

Identifieur interne : 000281 ( France/Analysis ); précédent : 000280; suivant : 000282

Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation

Auteurs : Pierre Vialat [France] ; Rolf Muller [France] ; Thuy Hang Vu [France] ; Christophe Prehaud [France] ; Michèle Bouloy [France]

Source :

RBID : ISTEX:449C81FDD66678800CD559729B01EC308BF9D8F3

English descriptors

Abstract

Abstract: The MP12 attenuated strain of Rift Valley fever virus was obtained by 12 serial passages of a virulent isolate ZH548 in the presence of 5-fluorouracil (Caplen et al., 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol., 66, 2271–2277). The comparison of the M segment of the two strains has already been reported by Takehara et al. (Takehara et al., 1989. Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus. Virology 169, 452–457). We have completed the comparison and found that altogether a total of nine, 12 and four nucleotides were changed in the L, M and S segments of the two strains, respectively. Three mutations induced amino acid changes in the L protein but none of them was located in the recognized motifs conserved among RNA dependent polymerases. In the S segment, a single change modified an amino acid in the NSs protein and in the M segment, seven of the mutations resulted in amino acid changes in each of the four encoded G1, G2, 14 kDa and 78 kDa proteins. Characterization of the MP12 virus indicated that determinants for attenuation were present in each segment and that they were introduced progressively during the 12 passages in the presence of the mutagen (Saluzzo and Smith, 1990. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8, 369–375). Passages 4 and 7–9 were found to be essential for introduction of temperature-sensitive lesions and attenuation. In an attempt to correlate some of the mutations with the attenuated or temperature-sensitive phenotypes, we determined by sequencing the passage level at which the different mutations appeared. This work should help to address the question of the role of the viral gene products in Rift Valley fever pathogenesis.

Url:
DOI: 10.1016/S0168-1702(97)00097-X


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:449C81FDD66678800CD559729B01EC308BF9D8F3

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation</title>
<author>
<name sortKey="Vialat, Pierre" sort="Vialat, Pierre" uniqKey="Vialat P" first="Pierre" last="Vialat">Pierre Vialat</name>
</author>
<author>
<name sortKey="Muller, Rolf" sort="Muller, Rolf" uniqKey="Muller R" first="Rolf" last="Muller">Rolf Muller</name>
</author>
<author>
<name sortKey="Vu, Thuy Hang" sort="Vu, Thuy Hang" uniqKey="Vu T" first="Thuy Hang" last="Vu">Thuy Hang Vu</name>
</author>
<author>
<name sortKey="Prehaud, Christophe" sort="Prehaud, Christophe" uniqKey="Prehaud C" first="Christophe" last="Prehaud">Christophe Prehaud</name>
</author>
<author>
<name sortKey="Bouloy, Michele" sort="Bouloy, Michele" uniqKey="Bouloy M" first="Michèle" last="Bouloy">Michèle Bouloy</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:449C81FDD66678800CD559729B01EC308BF9D8F3</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0168-1702(97)00097-X</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-RGPFZMVN-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F60</idno>
<idno type="wicri:Area/Istex/Curation">000F60</idno>
<idno type="wicri:Area/Istex/Checkpoint">000931</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000931</idno>
<idno type="wicri:doubleKey">0168-1702:1997:Vialat P:mapping:of:the</idno>
<idno type="wicri:Area/Main/Merge">001C07</idno>
<idno type="wicri:Area/Main/Curation">001B45</idno>
<idno type="wicri:Area/Main/Exploration">001B45</idno>
<idno type="wicri:Area/France/Extraction">000281</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation</title>
<author>
<name sortKey="Vialat, Pierre" sort="Vialat, Pierre" uniqKey="Vialat P" first="Pierre" last="Vialat">Pierre Vialat</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Laboratoire des Bunyaviridés, 25 rue du Dr Roux, 75724 Paris Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Muller, Rolf" sort="Muller, Rolf" uniqKey="Muller R" first="Rolf" last="Muller">Rolf Muller</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Laboratoire des Bunyaviridés, 25 rue du Dr Roux, 75724 Paris Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Vu, Thuy Hang" sort="Vu, Thuy Hang" uniqKey="Vu T" first="Thuy Hang" last="Vu">Thuy Hang Vu</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Laboratoire des Bunyaviridés, 25 rue du Dr Roux, 75724 Paris Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Prehaud, Christophe" sort="Prehaud, Christophe" uniqKey="Prehaud C" first="Christophe" last="Prehaud">Christophe Prehaud</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Laboratoire des Bunyaviridés, 25 rue du Dr Roux, 75724 Paris Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bouloy, Michele" sort="Bouloy, Michele" uniqKey="Bouloy M" first="Michèle" last="Bouloy">Michèle Bouloy</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Laboratoire des Bunyaviridés, 25 rue du Dr Roux, 75724 Paris Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Virus Research</title>
<title level="j" type="abbrev">VIRUS</title>
<idno type="ISSN">0168-1702</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">52</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="43">43</biblScope>
<biblScope unit="page" to="50">50</biblScope>
</imprint>
<idno type="ISSN">0168-1702</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0168-1702</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid substitution</term>
<term>Amino</term>
<term>Amino acid</term>
<term>Amino acid change</term>
<term>Amino acid changes</term>
<term>Amino acid substitutions</term>
<term>Attenuated</term>
<term>Attenuated phenotype</term>
<term>Attenuated strain</term>
<term>Attenuating</term>
<term>Attenuation</term>
<term>Candidate vaccine strain</term>
<term>Coding region</term>
<term>Coding regions</term>
<term>Determinant</term>
<term>Encephalitis virus</term>
<term>Envelope glycoproteins</term>
<term>Envelope protein</term>
<term>Family bunyaviridae</term>
<term>Genome</term>
<term>Glycoprotein</term>
<term>Intergenic</term>
<term>Intergenic region</term>
<term>Major determinant</term>
<term>Molecular biology</term>
<term>Molecular determinants</term>
<term>Mutation</term>
<term>Negative sense</term>
<term>Nucleotide</term>
<term>Open reading frame</term>
<term>Phenotype</term>
<term>Polygenic control</term>
<term>Polymerase</term>
<term>Preglycoprotein</term>
<term>Reassortant viruses</term>
<term>Recombinant vaccinia viruses</term>
<term>Rift</term>
<term>Rift valley fever</term>
<term>Rift valley fever virus</term>
<term>Rift valley fever virus vaccine</term>
<term>Segment</term>
<term>Segment codes</term>
<term>Serial passages</term>
<term>Single mutation</term>
<term>Structural proteins</term>
<term>Substitution</term>
<term>Takehara</term>
<term>Temperature sensitivity</term>
<term>Tissue tropism</term>
<term>Vaccine</term>
<term>Vaccine development</term>
<term>Venezuelan equine encephalitis virus</term>
<term>Vero cells</term>
<term>Vialat</term>
<term>Viral</term>
<term>Virol</term>
<term>Virology</term>
<term>Virulent</term>
<term>Virulent strain</term>
<term>Virus</term>
<term>Virus research</term>
<term>Yellow fever virus</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The MP12 attenuated strain of Rift Valley fever virus was obtained by 12 serial passages of a virulent isolate ZH548 in the presence of 5-fluorouracil (Caplen et al., 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol., 66, 2271–2277). The comparison of the M segment of the two strains has already been reported by Takehara et al. (Takehara et al., 1989. Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus. Virology 169, 452–457). We have completed the comparison and found that altogether a total of nine, 12 and four nucleotides were changed in the L, M and S segments of the two strains, respectively. Three mutations induced amino acid changes in the L protein but none of them was located in the recognized motifs conserved among RNA dependent polymerases. In the S segment, a single change modified an amino acid in the NSs protein and in the M segment, seven of the mutations resulted in amino acid changes in each of the four encoded G1, G2, 14 kDa and 78 kDa proteins. Characterization of the MP12 virus indicated that determinants for attenuation were present in each segment and that they were introduced progressively during the 12 passages in the presence of the mutagen (Saluzzo and Smith, 1990. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8, 369–375). Passages 4 and 7–9 were found to be essential for introduction of temperature-sensitive lesions and attenuation. In an attempt to correlate some of the mutations with the attenuated or temperature-sensitive phenotypes, we determined by sequencing the passage level at which the different mutations appeared. This work should help to address the question of the role of the viral gene products in Rift Valley fever pathogenesis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Vialat, Pierre" sort="Vialat, Pierre" uniqKey="Vialat P" first="Pierre" last="Vialat">Pierre Vialat</name>
</region>
<name sortKey="Bouloy, Michele" sort="Bouloy, Michele" uniqKey="Bouloy M" first="Michèle" last="Bouloy">Michèle Bouloy</name>
<name sortKey="Muller, Rolf" sort="Muller, Rolf" uniqKey="Muller R" first="Rolf" last="Muller">Rolf Muller</name>
<name sortKey="Prehaud, Christophe" sort="Prehaud, Christophe" uniqKey="Prehaud C" first="Christophe" last="Prehaud">Christophe Prehaud</name>
<name sortKey="Vu, Thuy Hang" sort="Vu, Thuy Hang" uniqKey="Vu T" first="Thuy Hang" last="Vu">Thuy Hang Vu</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000281 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000281 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:449C81FDD66678800CD559729B01EC308BF9D8F3
   |texte=   Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021